Home Open Access News Research & Innovation News

Research & Innovation News

Open Access Government has a massive variety of Scientific Research and Innovation information that is available in this category.

This section explores the latest breakthroughs in all aspects of science: including Biology, Chemistry, Physics, Psychology and Sociology. There is extensive research on psychological and social patterns that occur in everyday life.

Information is available on scientific policies that the government might adopt. Along with the changes and developments of global space policy. We cover the ongoing rise of anti-microbial resistance (AMR) and cancer research breakthroughs along with countries and their own individual research priorities.

Within this category we explore the massive increase and growth in CBD research and production, there is a lot of interesting information available.

interactive proof assistants, mathematics

Computer science, software and mathematics: Interactive proof assistants

Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.
genetic research

Finland: A framework for genetic research

Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.

How battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells

Dr Carlos Ziebert, head of IAM-AWP’s Calorimeter Center, KIT, explains how battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells.
transport and energy research

A gateway to transport and energy research: The Innovation and Networks Executive Agency

Dirk Beckers, Director of the Innovation and Networks Executive Agency, charts the important work of the organisation in supporting transport and energy research plus the ambitious Horizon Europe research and innovation framework programme (2021-2027).
placenta cells

Could placenta cells save patients with severe COVID-19?

Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
severe covid-19

Dementia gene doubles risk of developing severe COVID-19

Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.
immune mechanisms, cardiovascular

Targeting immune mechanisms underlying cardiovascular diseases

János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.
subacute thyroiditis

COVID-19 patients may be susceptible to developing subacute thyroiditis

The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
detecting pain, pain

Chemistry: Microfluidic devices for detecting pain

Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
global challenges

How are advanced materials part of the solution to our global challenges?

Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.
battle against COVID-19

Can nanotechnology aid the battle against COVID-19?

Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.
SARS-CoV-2

Modeling the whole-body dynamics of SARS-CoV-2 to investigate treatment strategies for effective management of...

Prashant Dogra1, Kavya Sinha2, Zhihui Wang1, Vittorio Cristini1,* 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas 2Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart...
25% of the uk, Res Consortium

Over 25% of the UK have already had COVID-19

Researchers from The University of Manchester, Salford Royal and Res Consortium prove that over 25% of the UK are likely to have contracted COVID-19 already.
oral health

The NIDCR: Advancing America’s oral health through research and innovation

Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
lockdown impact on alcohol, gambling

What is the lockdown impact on alcohol intake, gambling and porn use?

One of the key questions is soon to be answered by researchers, who will track lockdown impact on alcohol intake, gambling habits and porn watching.
robotic exploration

Subsurface sampling using High-Velocity impactors

Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.
umbilical cord

Umbilical cord stem cells have the potential to treat COVID-19

Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
chemistry research

Chemistry research: Driving discovery and development

The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
treat COVID-19, drug

Existing drugs should be used to treat COVID-19 instead of vaccine

Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
COVID-19 volunteer testing network

COVID-19 Volunteer Testing Network: Screening healthcare workers

Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.

Follow Open Access Government